Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion

Heart and Vessels

Volumn 29, Issue 1, 2014, Pages 110-118

  Sasaki, Toshiki ^a   Shishido, Tetsuro ^a   Kadowaki, Shinpei ^a   Kitahara, Tatsuro ^a   Suzuki, Satoshi ^b   Katoh, Shigehiko ^a   Funayama, Akira ^a   Netsu, Shunsuke ^a   Watanabe, Tetsu ^a   Goto, Kaoru ^a   Takeishi, Yasuchika ^b   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Diacylglycerol kinase; Protein kinase C; Reperfusion injury

Indexed keywords

CASPASE 3; DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; S6 KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOVASCULAR RISK; CELL COUNT; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION; HEART CATHETERIZATION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART INJURY; HEART MUSCLE CELL; INTRACELLULAR SIGNALING; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; RISK ASSESSMENT; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; APOPTOSIS; DIACYLGLYCEROL KINASE; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SYSTOLE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 84897439655     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-013-0366-6     Document Type: Article

References (37)

1. Pan MW, Chen SY, Chen CC, Chen WJ, Chang CJ, Lin CP, Weng YM, Chen YC (2013) Implementation of multiple strategies for improved door-to-balloon time in patients with ST-segment elevation myocardial infarction. Heart Vessels. doi: 10.1007/s00380-013-0336-z
2. Akdemir R, Karakurt O, Kilic H, Yesilay AB, Dogan M, Cagirci G, Acikel S, Akdemir N (2010) Effect of reperfusion therapy on index of myocardial performance in acute myocardial infarction: thrombolytics versus primary angioplasty. Heart Vessels 25:87-91
3. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ (2005) Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100:179-190
4. Bagatini MD, Martins CC, Battisti V, Gasparetto D, da Rosa CS, Spanevello RM, Ahmed M, Schmatz R, Schetinger MR, Morsch VM (2011) Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels 26:55-63
5. Zhao ZQ, Vinten-Johansen J (2002) Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 55:438-455
6. Piper HM, Siegmund B, Ladilov YuV, Schluter KD (1993) Calcium and sodium control in hypoxic-reoxygenated cardiomyocytes. Basic Res Cardiol 88:471-482
7. Marber MS, Latchman DS, Walker JM, Yellon DM (1993) Cardiac stress protein elevation 24 h after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88:1264-1272 (Pubitemid 23264047)
8. Abe J, Baines CP, Berk BC (2000) Role of mitogen-activated protein kinases in ischemia and reperfusion injury: the good and the bad. Circ Res 86:607-609 (Pubitemid 30208424)
9. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH (2000) Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86:692-699 (Pubitemid 30208438)
10. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ (2001) p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 98:9666-9670 (Pubitemid 32769360)
11. Goto K, Kondo H (1996) A 104-kDa diacylglycerol kinase containing ankyrin-like repeats localizes in the cell nucleus. Proc Natl Acad Sci USA 93:11196-11201 (Pubitemid 26333141)
12. Takeda M, Kagaya Y, Takahashi J, Sugie T, Ohta J, Watanabe J, Shirato K, Kondo H, Goto K (2001) Gene expression and in situ localization of diacylglycerol kinase isozymes in normal and infarcted rat hearts: effects of captopril treatment. Circ Res 89:265-272 (Pubitemid 34132685)
13. Takahashi H, Takeishi Y, Seidler T, Arimoto T, Akiyama H, Hozumi Y, Koyama Y, Shishido T, Tsunoda Y, Niizeki T, Nozaki N, Abe J, Hasenfuss G, Goto K, Kubota I (2005) Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy. Circulation 111:1510-1516 (Pubitemid 40470646)
14. Bilim O, Shishido T, Toyama S, Suzuki S, Sasaki T, Kitahara T, Sadahiro M, Takeishi Y, Kubota I (2011) Differential regulation of diacylglycerol kinase isoform in human failing hearts. J Cardiothorac Surg 6:65
15. Yahagi H, Takeda M, Asaumi Y, Okumura K, Takahashi R, Takahashi J, Ohta J, Tada H, Minatoya Y, Sakuma M, Watanabe J, Goto K, Shirato K, Kagaya Y (2005) Differential regulation of diacylglycerol kinase isozymes in cardiac hypertrophy. Biochem Biophys Res Commun 332:101-108 (Pubitemid 40723596)
16. Inagaki K, Hahn HS, Dorn GW 2nd, Mochly-Rosen D (2003) Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation 108:869-875 (Pubitemid 37022131)
17. Shishido T, Woo CH, Ding B, McClain C, Molina CA, Yan C, Yang J, Abe J (2008) Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction. Circ Res 102:1416-1425
18. Yan C, Ding B, Shishido T, Woo CH, Itoh S, Jeon KI, Liu W, Xu H, McClain C, Molina CA, Blaxall BC, Abe J (2007) Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res 100:510-519 (Pubitemid 46673260)
19. Shishido T, Nozaki N, Takahashi H, Arimoto T, Niizeki T, Koyama Y, Abe J, Takeishi Y, Kubota I (2006) Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury. Biochem Biophys Res Commun 345:1446-1453 (Pubitemid 43817893)
20. Arimoto T, Takeishi Y, Takahashi H, Shishido T, Niizeki T, Koyama Y, Shiga R, Nozaki N, Nakajima O, Nishimaru K, Abe J, Endoh M, Walsh RA, Goto K, Kubota I (2006) Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice. Circulation 113:60-66 (Pubitemid 43958489)
21. Pawlinski R, Tencati M, Hampton CR, Shishido T, Bullard TA, Casey LM, Andrade-Gordon P, Kotzsch M, Spring D, Luther T, Abe J, Pohlman TH, Verrier ED, Blaxall BC, Mackman N (2007) Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation 116:2298-2306 (Pubitemid 350100336)
22. Suzuki S, Shishido T, Funayama A, Netsu S, Ishino M, Kitahara T, Sasaki T, Katoh S, Otaki Y, Watanabe T, Shibata Y, Mantovani A, Takeishi Y, Kubota I (2013) Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction. PLoS One 8:e53133
23. Maekawa N, Abe J, Shishido T, Itoh S, Ding B, Sharma VK, Sheu SS, Blaxall BC, Berk BC (2006) Inhibiting p90 ribosomal S6 kinase prevents (Na?)-H? exchanger-mediated cardiac ischemia-reperfusion injury. Circulation 113:2516-2523 (Pubitemid 43948030)
24. Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, Takahashi H, Arimoto T, Maeda K, Yamakawa M, Takeuchi O, Akira S, Takeishi Y, Kubota I (2003) Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108:2905-2910 (Pubitemid 37517819)
25. Miyamoto T, Takeishi Y, Takahashi H, Shishido T, Arimoto T, Tomoike H, Kubota I (2004) Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload. Basic Res Cardiol 99:328-337 (Pubitemid 39236723)
26. Niizeki T, Takeishi Y, Arimoto T, Takahashi H, Shishido T, Koyama Y, Goto K, Walsh RA, Kubota I (2007) Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction. Am J Physiol Heart Circ Physiol 292:H1105-H1112
27. Nozaki N, Shishido T, Takeishi Y, Kubota I (2004) Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 110:2869-2874 (Pubitemid 39473611)
28. Krieg T, Qin Q, McIntosh EC, Cohen MV, Downey JM (2002) ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol Heart Circ Physiol 283:H2322-H2330 (Pubitemid 35345936)
29. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM (1999) Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31:1937-1948 (Pubitemid 29458710)
30. Cenni V, Doppler H, Sonnenburg ED, Maraldi N, Newton AC, Toker A (2002) Regulation of novel protein kinase C epsilon by phosphorylation. Biochem J 363:537-545 (Pubitemid 34526374)
31. Dhalla NS, Xu YJ, Sheu SS, Tappia PS, Panagia V (1997) Phosphatidic acid: a potential signal transducer for cardiac hypertrophy. J Mol Cell Cardiol 29:2865-2871 (Pubitemid 27510754)
32. Exton JH (1997) Phospholipase D: enzymology, mechanisms of regulation, and function. Physiol Rev 77:303-320
33. Moraru II, Popescu LM, Maulik N, Liu X, Das DK (1992) Phospholipase D signaling in ischemic heart. Biochim Biophys Acta 1139:148-154
34. Guo R, Wan CK, Carpenter JH, Mousallem T, Boustany RM, Kuan CT, Burks AW, Zhong XP (2008) Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta. Proc Natl Acad Sci USA 105:11909-11914
35. Fang X, Yu S, Eder A, Mao M, Bast RC Jr, Boyd D, Mills GB (1999) Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene 18:6635-6640
36. Scheid MP, Schubert KM, Duronio V (1999) Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J Biol Chem 274:31108-31113
37. Weston CR, Balmanno K, Chalmers C, Hadfield K, Molton SA, Ley R, Wagner EF, Cook SJ (2003) Activation of ERK1/2 by deltaRaf-1:ER*represses Bim expression independently of the JNK or PI3K pathways. Oncogene 22:1281-1293 (Pubitemid 36388747)